1. Articles from Notal Vision

    1-5 of 5
    1. Home OCT longitudinal home-based study with patient self-operated device has begun

      Home OCT longitudinal home-based study with patient self-operated device has begun

      Notal Vision is proud to announce the enrollment of patients in the first longitudinal home-based study with its investigational home optical coherence tomography (OCT) remote monitoring device. The study will explore the daily dynamics of retinal fluid in patients receiving anti-VEGF treatment for wet age-related macular degeneration (AMD). The Home OCT System pipeline technology is designed to provide home-based, patient-initiated retinal OCT scans to support the management of patients with wet AMD, complementing existing standard of care treatments as well as emerging longer acting drugs and drug delivery systems. “The study is an important milestone for our Home OCT pipeline ...

      Read Full Article
    2. AI-based retinal fluid analytics of serial Notal Vision home OCT images offers insights into retinal disease dynamics

      AI-based retinal fluid analytics of serial Notal Vision home OCT images offers insights into retinal disease dynamics

      Longitudinal data on retinal imaging of age-related macular degeneration (AMD) patients using the final form factor of Notal Vision’s home OCT (NOTAL-OCT V3.0) was presented at the Angiogenesis, Exudation, and Degeneration meeting in Miami. The pipeline technology is designed to use home-based, patient-initiated retinal OCT scans to support the management of patients with exudative AMD, complementing existing standard of care as well as emerging longer acting drugs and drug delivery systems. “This is the first time nano-liter scale quantities of intra- and subretinal fluid have been tracked over time based on home OCT images and deep learning retinal ...

      Read Full Article
    3. CPT codes for home OCT established

      CPT codes for home OCT established

      The AMA’s CPT® Editorial Panel has accepted three new category III codes for reporting patient-initiated remote retinal OCT scans, facilitated by Notal Vision’s home-based OCT pipeline technology Notal Vision, Inc., a privately held ophthalmic diagnostic services company focused on advancing eye care with precision medicine by extending disease management from the clinic to the home, announced today that the American Medical Association’s (AMA) Current Procedural Terminology (CPT) Editorial Panel has established three new Category III codes (0604T, 0605T, 0606T) to report patient-initiated remote retinal optical coherence tomography (OCT) scans, which is performed using Notal Vision’s home-based ...

      Read Full Article
    4. Notal Vision Announces Appointment of Dr. Kester Nahen as Chief Executive Officer

      Notal Vision Announces Appointment of Dr. Kester Nahen as Chief Executive Officer

      Notal Vision, Ltd., a privately held ophthalmic company focused on advancing eye care with precision medicine by extending disease management from the clinic to the home, is pleased to announce the appointment of Kester Nahen, PhD as Chief Executive Officer. Dr. Nahen joined the company as Chief Commercial Officer in August 2019, bringing a wealth of global leadership experience in the medical device industry to his new position. "I am delighted that Kester Nahen has accepted the offer to be Chief Executive Officer and lead Notal Vision through the company's next phase of growth and beyond," said Guy Katsav ...

      Read Full Article
    5. Dr. Kester Nahen joins Notal Vision as Chief Commercial Officer

      Dr. Kester Nahen joins Notal Vision as Chief Commercial Officer

      Notal Vision, Inc., a company focused on advancing eye care with precision medicine by extending disease management from the clinic to the home, is pleased to announce the appointment of Kester Nahen, PhD to Chief Commercial Officer. Dr. Nahen is a medical device industry expert and brings more than 18 years of well-rounded international business experience in product management, medical science, clinical research, marketing, sales, professional education, and business development to the company. "I am delighted to welcome Kester to the Notal Vision executive team,” stated Dr. Susan Orr, Chief Executive Officer of Notal Vision. “I am confident that his ...

      Read Full Article
    1-5 of 5
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics in the News

    1. (5 articles) Kester Nahen
    2. (5 articles) Notal Vision
    3. (2 articles) FDA
    4. (2 articles) University of Lübeck
    5. (2 articles) Susan Orr
    6. (1 articles) National Eye Institute
  3. Popular Articles

  4. Picture Gallery

    Dr. Kester Nahen joins Notal Vision as Chief Commercial Officer Notal Vision Announces Appointment of Dr. Kester Nahen as Chief Executive Officer CPT codes for home OCT established AI-based retinal fluid analytics of serial Notal Vision home OCT images offers insights into retinal disease dynamics Home OCT longitudinal home-based study with patient self-operated device has begun Operation Night Watch: getting closer to Rembrandt despite distancing Anatomical and functional healing after resorbable magnesium scaffold implantation in human coronary vessels: A combined optical coherence tomography and quantitative flow ratio analysis "Predicting Glaucoma Progression With Optical Coherence Tomography Structural and Angiographic Parameters". Intravascular Imaging-Guided Percutaneous Coronary Intervention: A Universal Approach for Optimization of Stent Implantation Clinical Usefulness of a Novel Optical Coherence Tomography Procedure, “Low Molecular Weight Dextran Infusion Followed by Catheter PUSH (D-PUSH)” Optical Coherence Tomography to Guide Percutaneous Coronary Intervention of the Left Main Coronary Artery: the LEMON study Impact of optical coherence tomography findings on clinical outcomes in ST-segment elevation myocardial infarction patients: a MATRIX (Minimizing Adverse Hemorrhagic Events by Trans-radial Access Site and angioX) OCT sub-study